Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
1 cosponsor · 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- Senate Introduced Feb 2, 2021
- Senate Passed Mar 3, 2021
- House Passed Apr 14, 2021 412–8
- President To the President Apr 20, 2021
- President Signed Apr 23, 2021
- Law Apr 23, 2021
This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars.
What it does: CRS summary · Public Law · Apr 23, 2021
Advancing Education on Biosimilars Act of 2021
This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.)
The FDA may also maintain and operate a website to provide educational materials about biological products.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
Votes to become law
About this bill and sources
Official title: Advancing Education on Biosimilars Act of 2021
Latest action (Apr 23, 2021): Became Public Law No: 117-8.
Policy area: Health · Origin: Senate · Introduced: Feb 2, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML) · Embed in your story
- Senate Introduced Feb 2, 2021
- Senate Passed Mar 3, 2021
- House Passed Apr 14, 2021 412–8
- President To the President Apr 20, 2021
- President Signed Apr 23, 2021
- Law Apr 23, 2021
Final vote · House · Apr 14, 2021
Passage (two-thirds required) — Passed. Vote details
Speaker of the House: Nancy Pelosi